Gilead Sciences (GILD) Minority Interest (2009 - 2026)

Gilead Sciences has reported Minority Interest for 18 years, with the latest figure at -$84.0 million in Q1 2026.

• For the quarter ending Q1 2026, Minority Interest changed 0.0% year-over-year to -$84.0 million; the trailing twelve-month figure through Mar 2026 stood at -$84.0 million (changed 0.0% YoY), and the FY2025 full-year result was -$84.0 million, changed 0.0% from the prior year.
• Minority Interest for Q1 2026 stood at -$84.0 million, roughly flat from -$84.0 million in the prior quarter.
• The five-year high for Minority Interest was -$12.0 million in Q1 2022, with the low at -$84.0 million in Q4 2023.
• Historically, Minority Interest has averaged -$66.0 million across 5 years, with a median of -$84.0 million in 2023.
• Annual changes were most pronounced in 2022 — Minority Interest plunged 2500.0% — and 2024, when it changed 0.0%.
• Gilead Sciences' Minority Interest stood at -$31.0 million in 2022, then tumbled by 170.97% to -$84.0 million in 2023, then changed by 0.0% to -$84.0 million in 2024, then changed by 0.0% to -$84.0 million in 2025, then changed by 0.0% to -$84.0 million in 2026.
• The last three Minority Interest figures came in at -$84.0 million (Q1 2026), -$84.0 million (Q4 2025), and -$84.0 million (Q3 2025), per Business Quant data.